一次性经食管超声心动图探头血流动力学监测在危重患者中的随机对照试验研究方案
主要结局为从入组到循环性休克缓解的时间,休克缓解定义为停用血管活性药物后MAP>60 mmHg持续≥4小时。研究旨在评估hTEE技术是否较标准监测缩短休克缓解时间。
要点
- hTEE监测通过三个定义切面评估左室面积变化率、右左室面积比和上腔静脉塌陷指数。
- 主要结局为停用血管活性药物后MAP>60 mmHg持续≥4小时的休克缓解时间。
- 采用竞争风险模型分析时间-事件结局,考虑死亡竞争风险。
核心结论
- 该研究可能为首批提供超声心动图指导循环性休克治疗有效性和安全性详细数据的试验之一。
研究设计与样本
- 随机对照试验,采用2×2析因设计,按血流动力学监测方法(hTEE vs 标准监测)和评估频率(至少每4小时 vs 常规)分层。
关键数值与推荐
- 主要结局为从入组到循环性休克缓解的时间,缓解定义为停用血管升压药和正性肌力药后MAP>60 mmHg持续≥4小时。
- hTEE监测包括三个切面:经胃中段食管短轴测量左室面积变化率、中段食管四腔心测量右左室面积比、中段食管升主动脉短轴测量上腔静脉塌陷指数。
- 对照组监测方式包括常规经胸和经食管超声但不包括hTEE,由治疗医生决定。
临床怎么用
- 研究结果可能为ICU循环性休克患者的血流动力学监测选择提供证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hemodynamic instability is one of the leading causes of intensive care unit (ICU) admission. Early stabilization of hemodynamics is associated with improved outcome. The monitoring used to guide hemodynamic support may influence the time needed to achieve stable hemodynamics. Visualization of the heart using echocardiography offers the advantage of direct measurement of cardiac volumes and ventricular function. A miniaturized monoplane transesophageal echocardiography (TEE) probe was developed, allowing for almost continuous qualitative hemodynamic TEE assessment (hTEE) after brief bedside training. The primary objective of the study is to assess whether hemodynamic monitoring using the hTEE technology shortens time to resolution of shock in ICU patients in comparison to standard monitoring using a central venous catheter, pulmonary artery catheter, or conventional echocardiography. METHODS: Five hundred consecutive subjects with circulatory shock (low mean arterial blood pressure (MAP) and signs of organ hypoperfusion) at the time of ICU admission are included in the study. The subjects are randomly assigned to one of four groups using a 2 × 2 factorial design stratified by method of hemodynamic monitoring (hTEE vs standard hemodynamic monitoring) and frequency of hemodynamic assessments (minimum every 4 h vs standard of care). The primary study outcome is the time from study inclusion to resolution of circulatory shock, defined as MAP > 60 mmHg for ≥ 4 h after discontinuation of vasopressors and inotropes. The hTEE monitoring consists of the acquisition of three defined echocardiography views: Transgastric mid-esophageal short axis with measurement of fractional area change of left ventricle, mid-esophageal four-chamber view with measurement of the ratio of right to left ventricular area, and mid-esophageal ascending aortic short-axis view with measurement of the superior vena cava collapsibility index. In the control groups, monitoring modalities, including conventional TTE and TEE but not hTEE, are at the discretion of the treating physician. The interpretation of hemodynamic monitoring and the subsequent changes in patient management are recorded after each hemodynamic assessment. Differences in the primary and further secondary time-to-event outcomes will be assessed using a competing risk model accounting for the competing risk of death. DISCUSSION: The effect of using echocardiography as a monitoring modality on relevant patient outcomes has not been established so far. The study at hand may be one of the first trials to provide detailed data on effectiveness and safety of echocardiography to guide treatment in patients with circulatory shock. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT02048566. Registered on January 29, 2014.
引用
- Cioccari L, Zante B, Bloch A, et al. Effects of hemodynamic monitoring using a single-use transesophageal echocardiography probe in critically ill patients - study protocol for a randomized controlled trial. Trials. 2018. PMID: 29980233. doi:10.1186/s13063-018-2714-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。